Study Designed to Evaluate the Effect of CimetrA in Patients Diagnosed With COVID-19
Clinical trial NCT05037162 · COMPLETED
Trial details
- NCT number
- NCT05037162
- Sponsor
- MGC Pharmaceuticals d.o.o
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-11
- Primary completion
- 2023-01-21
- Enrollment
- 240
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.